Cargando…

Profile of crizanlizumab and its potential in the prevention of pain crises in sickle cell disease: evidence to date

Sickle cell disease (SCD) is one of the most common inherited blood disorders globally. It is a grouping of autosomal recessive genetic disorders identified by a genetic mutation that replaces glutamic acid with valine at the sixth amino acid on the hemoglobin β-globin chain. Millions of people arou...

Descripción completa

Detalles Bibliográficos
Autores principales: Riley, Tanya R, Riley, Treavor T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720158/
https://www.ncbi.nlm.nih.gov/pubmed/31507334
http://dx.doi.org/10.2147/JBM.S191423